The clinical implications of aromatase are vast, particularly in the context of hormone therapy. Aromatase inhibitors are widely used in the treatment of postmenopausal women with hormone receptor-positive breast cancer. These inhibitors reduce estrogen production, thereby limiting the growth stimulus for cancer cells. Moreover, understanding the role of aromatase in bone health has implications for conditions like osteoporosis, where estrogen plays a protective role.
